Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.45 |
| ▸ | HTR7 | P34969 | 2/20 | 0.44 |
| ▸ | HTR1B | P28222 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 2/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | FLT3 | P36888 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4852186 | 0.96 | SLC6A9 (0.46) | KDM4ESLC6A9HTR7ALDH1A1MEN1 | |
| SCHEMBL4845580 | 0.93 | SLC6A9 (0.49) | KDM4ESLC6A9HTR7ALDH1A1MEN1 | |
| SCHEMBL4852357 | 0.89 | SLC6A9 (0.42) | KDM4ESLC6A9HTR7ALDH1A1MEN1 | |
| SCHEMBL4849739 | 0.88 | ALDH1A1 (0.46) | KDM4ESLC6A9ALDH1A1MEN1MAPT | |
| SCHEMBL4846256 | 0.88 | SLC6A9 (0.41) | KDM4ESLC6A9HTR7ALDH1A1MEN1 | |
| SCHEMBL4853716 | 0.84 | HTR7 (0.48) | KDM4ESLC6A9HTR7ALDH1A1HRH1 | |
| SCHEMBL4851155 | 0.83 | SLC6A9 (0.46) | KDM4ESLC6A9HTR7ALDH1A1MEN1 | |
| SCHEMBL4854976 | 0.83 | CYP1A2 (0.47) | KDM4EHTR1BALDH1A1MEN1MAPT | |
| SCHEMBL4854461 | 0.83 | DRD2 (0.46) | KDM4ESLC6A9ALDH1A1MEN1MAPT | |
| SCHEMBL7936530 | 0.80 | ERN1 (0.51) | KDM4EALDH1A1MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7423181-B2 | in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone | LICA PHARMACEUTICALS A/S (DK) | 2008-09-09 | — | — | US | disclosed |
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | disclosed |
| EP-1515940-A2 | AMINOALKOXY-FUNCTIONAL CHALCONES | Lica Pharmaceuticals A/S (DK) | 2005-03-23 | — | — | EP | disclosed |
| WO-2003097574-A2 | AMINOALKOXY-FUNCTIONAL CHALCONES | LICA PHARMACEUTICALS A/S (DK) | 2003-11-27 | — | — | WO | disclosed |